Is stem cell therapy for Intellectual Disability FDA-approved?
No generic stem-cell or exosome product is FDA-approved to treat intellectual disability. A trial listing, hospital credential or product described as neural does not constitute approval for a developmental indication.
How stem cells are studied for Intellectual Disability
Intellectual disability is the current clinical term; the older label retained in this source slug is outdated and should not appear in patient-facing text. Intellectual disability has many genetic, prenatal, perinatal, metabolic and acquired causes and is defined through intellectual and adaptive functioning. A generic cell infusion cannot be assumed to address those different causes or reverse established developmental differences.
Am I a candidate? → · Intellectual Disability: full overview → · Intellectual Disability cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.